Navigation Links
NASA selects DNA Medicine Institute's Nanoscale Diagnostics Technology for Phase II SBIR
Date:1/28/2010

CAMBRIDGE, Mass., Jan. 28 /PRNewswire/ -- DNA Medicine Institute, a commercial organization focused on advancing human health through innovation, today announced it has been awarded a Phase II Small Business Innovation Research (SBIR) contract from the National Aeronautics and Space Administration (NASA).  The contract is designed to develop nanoscale diagnostic technologies that facilitate whole health analysis in a single drop of blood.  The Institute will develop assays for assessment of bone loss, immune function, cardiac health, liver function, and lipid status.  The nanoscale diagnostic platform is designed to make hospital tests, currently performed on large machines with trained personnel, possible under any scenario.  This includes confined space flight environments and other field settings where medical information is vital, but inaccessible.  The Institute envisions that this technology will be used in conjunction with its Universal Blood Sensor platform designed to shrink a hospital testing lab onto a handheld, point-of-care device.

"We are pleased to work with NASA in developing technologies for monitoring crew health during space flight, including journeys to the space station and other manned space missions," said Eugene Y. Chan, M.D., President and Chief Scientific Officer of the DNA Medicine Institute.  "This funding will allow us to develop innovations for diagnosing medical conditions in unique environments with minimal amounts of blood and reagents."

The DNA Medicine Institute was awarded a Phase I NASA SBIR grant in 2008.  During this Phase I project, the Institute met key milestones for developing novel nanoscale diagnostic technologies.

About DNA Medicine Institute

The DNA Medicine Institute is a commercial organization whose mission is to advance patient care, alleviate human suffering, and treat disease through innovation.  Founded by Eugene Y. Chan, M.D., its core beliefs are that successful, innovative commercial products can make a long-lasting impact on patient care.  It currently does research on intuitive medical devices, smartly designed drugs, and powerful research instrumentation.  One of these is the Universal Blood Sensor, a technology designed to perform a full health analysis of a person, anywhere, anytime, and with a single drop of blood.  The DNA Medicine Institute's multi-faceted approach to innovation draws upon diverse fields including medicine, nanotechnology, genomics, biophysics, biochemistry, molecular biology, and advanced engineering.  For more information, visit:  www.dnamedinstitute.com.

SOURCE DNA Medicine Institute


'/>"/>
SOURCE DNA Medicine Institute
Copyright©2010 PR Newswire.
All rights reserved

Related medicine news :

1. Central Garden & Pet Selects SiteHawk as Its MSDS Management Provider
2. NewYork-Presbyterian Hospital Selects Omnicell for Medication Management
3. Virtua Selects Nuvon, Inc. as its Device Connectivity and Integration Solution Provider
4. Legacy Health Selects Allscripts Care Management for Hospitals and Post-Acute Care Facilities
5. Catholic Health Initiatives Selects Allscripts Electronic Health Record for Over 1000 Physicians in 19 States
6. Renaissance Medical Management Company Selects Allscripts Electronic Health Record and Practice Management
7. New Mexico VA Health Care System Selects Sensotech Wireless Temperature Monitoring System
8. bioMerieux Selects Brainware to Automate Accounts Payable
9. Blue Cross Blue Shield of Michigan Selects Kevin Klobucar to Lead Blue Care Network as President
10. Lifespace Communities Selects StaffKnex Software for Nurse Scheduling and Employee Communications
11. Baptist Health System Selects HealthScreen Disease Management for Employee Health Management Services
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... ... ... enough sleep affects much more than energy – it also has mental and physical benefits. ... motor reaction time, which can increase the risk of having a car accident. , ... the NSF to help you sleep better and feel better:, , ...
(Date:4/28/2017)... ... April 28, 2017 , ... ... http://www.wiredlifesolutions.com , “Computers are everywhere and they’re here to stay,” said ... Global Climate Change and Your Health on Voice America sponsored by Nature’s Tears® ...
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... The ... board members and officers for 2017-2018. The annual board election process has been in ... a volunteer basis. , Thomas C. Dickerson, Ed.D., FACHE, succeeds Jim Hamilton, MHA, CMM, ...
(Date:4/28/2017)... ... April 28, 2017 , ... Children and adolescents who ... experiences than children in the general population. That’s because foster care is designed ... family challenges. While no fault of their own, youth who have experienced trauma ...
(Date:4/28/2017)... Harbor, Md. (PRWEB) , ... April 28, 2017 ... ... Care Association of America (UCAOA) and College of Urgent Care Medicine will host ... 2017 workshops, sessions and speakers will help those in the industry adapt to ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... 2017  AbbVie (NYSE: ABBV), a global biopharmaceutical ... chronic hepatitis C virus (HCV) infected patients with ... compensated cirrhosis (Child-Pugh A) achieved sustained virologic response ... its investigational, pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). These ... 12 weeks of G/P treatment without ribavirin. Patients ...
(Date:4/20/2017)... Sweden , April 20, 2017 ... NEVPF) ("NeuroVive") today announced positive preclinical results ... preclinical compound for non-alcoholic steatohepatitis (NASH), in ... NV556 has previously shown ... NASH model. Today, NeuroVive,s scientists present novel ...
(Date:4/19/2017)... , April 19, 2017 Cardiology devices segment ... projected period The Cardiology Devices segment is likely ... US$ 15 Mn in 2018 over 2017. By the end ... market valuation close to US$ 700 Mn, expanding at a ... segment dominated the Asia Pacific reprocessed ...
Breaking Medicine Technology: